Hyperfibrinolysis drives mechanical instabilities in a simulated model of trauma induced coagulopathy

Thromb Res. 2022 Dec:220:131-140. doi: 10.1016/j.thromres.2022.10.017. Epub 2022 Oct 29.

Abstract

Introduction: Trauma induced coagulopathy (TIC) is common after severe trauma, increasing transfusion requirements and mortality among patients. TIC has several phenotypes, with primary hyperfibrinolysis being among the most lethal. We aimed to investigate the contribution of hypercoagulation, hemodilution, and fibrinolytic activation to the hyperfibrinolytic phenotype of TIC, by examining fibrin formation in a plasma-based model of TIC. We hypothesized that instabilities arising from TIC will be due primarily to increased fibrinolytic activation rather than hemodilution or tissue factor (TF) induced hypercoagulation.

Methods: The influence of TF, hemodilution, fibrinogen consumption, tissue plasminogen activator (tPA), and the antifibrinolytic tranexamic acid (TXA) on plasma clot formation and structure were examined using rheometry, optical properties, and confocal microscopy. These were then compared to plasma samples from trauma patients at risk of developing TIC.

Results: Combining TF-induced clot formation, 15 % hemodilution, fibrinogen consumption, and tPA-induced fibrinolysis, the clot characteristics and hyperfibrinolysis were consistent with primary hyperfibrinolysis. TF primarily increased fibrin polymerization rates and reduced fiber length. Hemodilution decreased clot optical density but had no significant effect on mechanical clot stiffness. TPA addition induced primary clot lysis as observed mechanically and optically. TXA restored mechanical clot formation but did not restore clot structure to control levels. Patients at risk of TIC showed increased clot formation, and lysis like that of our simulated model.

Conclusions: This simulated TIC plasma model demonstrated that fibrinolytic activation is a primary driver of instability during TIC and that clot mechanics can be restored, but clot structure remains altered with TXA treatment.

Keywords: Blood; Fibrin; Fibrinolysis; Hemorrhage; Mechanics.

MeSH terms

  • Blood Coagulation Disorders* / etiology
  • Fibrin
  • Fibrinogen
  • Hemodilution
  • Hemostatics*
  • Humans
  • Thrombophilia*
  • Thromboplastin
  • Tissue Plasminogen Activator
  • Tranexamic Acid*

Substances

  • Tissue Plasminogen Activator
  • Tranexamic Acid
  • Thromboplastin
  • Fibrinogen
  • Hemostatics
  • Fibrin